Related Experiment Video
Updated: Oct 7, 2025

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
Cost analysis of treating cardiovascular diseases in a super-specialty hospital
Atul Kumar1, Vijaydeep Siddharth1, Soubam Iboyaima Singh1
1Department of Hospital Administration, All India Institute of Medical Sciences (AIIMS), New Delhi, India.
Insights
Economic evaluation of cardiovascular disease (CVD) treatment in India reveals significant inpatient and equipment costs. Rheumatic heart disease treatment is most expensive, though overall costs are lower than in developed nations.
Area of Science:
- Health Economics
- Cardiology
- Public Health Policy
Background:
- Cardiovascular diseases (CVDs) represent a significant global health burden.
- Economic evaluations are crucial for optimizing resource allocation in healthcare, particularly in developing countries with limited data.
- Understanding the cost of CVD treatment is essential for healthcare policy and planning.
Purpose of the Study:
- To analyze resource consumption and calculate the cost of treating cardiovascular disease patients in a tertiary care hospital in India.
- To compare the cost of treating different types of CVDs.
- To provide data for healthcare policy reforms in India.
Main Methods:
- An observational, descriptive study conducted at the All India Institute of Medical Sciences, New Delhi, from April 2017 to June 2018.
- Inclusion of common CVDs such as Coronary Artery Disease (CAD), Rheumatic Heart Disease (RHD), Cardiomyopathy, Congenital heart diseases, and Cardiac Arrhythmias.
- Utilized Traditional Costing and Time-Driven Activity-Based Costing (TDABC) methods for cost computation, analyzing medical records of 100 admitted patients.
Main Results:
- Per bed per day costs ranged from Indian Rupee (INR) 18,774 (US$ 289) in pediatric cardiology wards to INR 28,144 (US$ 434) in the Cardiac Care Unit.
- Inpatient costs formed approximately 70% of the total cost, with equipment (over 50%) and human resources (28%) being major components.
- The average cost per patient for treating any CVD was INR 2,47,822 (US$ 3842), with Rheumatic Heart Disease being the most expensive to treat.
Conclusions:
- Cardiovascular disease treatment costs in India are substantial, with significant contributions from inpatient stays and medical equipment.
- Rheumatic Heart Disease treatment incurs the highest costs among studied CVDs.
- The findings suggest that CVD treatment costs in India are lower compared to developed countries, providing valuable insights for Indian healthcare policy makers.
Abstract:
Cardiovascular care is expensive; hence, economic evaluation is required to estimate resources being consumed and to ensure their optimal utilization. There is dearth of data regarding cost analysis of treating various diseases including cardiac diseases from developing countries. The study aimed to analyze resource consumption in treating cardio-vascular disease patients in a super-specialty hospital. An observational and descriptive study was carried out from April 2017 to June 2018 in the Department of Cardiology, Cardio-Thoracic (CT) Centre of All India Institute of Medical Sciences, New Delhi, India. As per World Health Organization, common cardiovascular diseases i.e. Coronary Artery Disease (CAD), Rheumatic Heart Disease (RHD), Cardiomyopathy, Congenital heart diseases, Cardiac Arrhythmias etc. were considered for cost analysis. Medical records of 100 admitted patients (Ward & Cardiac Care Unit) of cardiovascular diseases were studied till discharge and number of patient records for a particular CVD was identified using prevalence-based ratio of admitted CVD patient data. Traditional Costing and Time Driven Activity Based Costing (TDABC) methods were used for cost computation. Per bed per day cost incurred by the hospital for admitted patients in Cardiac Care Unit, adult and pediatric cardiology ward was calculated to be Indian Rupee (INR) 28,144 (US$ 434), INR 22,210 (US$ 342) and INR 18,774 (US$ 289), respectively. Inpatient cost constituted almost 70% of the total cost and equipment cost accounted for more than 50% of the inpatient cost followed by human resource cost (28%). Per patient cost of treating any CVD was computed to be INR 2,47,822 (US $ 3842). Cost of treating Rheumatic Heart Disease was the highest among all CVDs followed by Cardiomyopathy and other CVDs. Cost of treating cardiovascular diseases in India is less than what has been reported in developed countries. Findings of this study would aid policy makers considering recent radical changes and massive policy reforms ushered in by the Government of India in healthcare delivery.
More Related Videos
07:51Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
13:07Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Cardiomyopathy V: Interprofessional Care
Acute Coronary Syndrome IV: Interprofessional Care
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Heart Failure VI: Adjunct Therapies
Secondary Healthcare System